glp 1 in heart failure GLP-1 Agonists Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies GLP-1 receptor agonists as promising

Repeated injections in the same spot can cause lipohypertrophy, where fatty tissue thickens and potentially slows future medication absorption

Endothelial senescence (2025, PMC) Reported FOXO4-DRI clearing senescent endothelial cells via a p53/BCL-2/caspase-3 pathway in animal and cell models

Gala GLP-1's stated pricing is positioned within the range of publicly available pricing across telehealth GLP-1 platforms at the time of writing - though direct comparisons require verifying exactly what's included at each tier across platforms, as these structures shift frequently

Common options include: Exenatide (Byetta): Two times a day injection Liraglutide (Victoza, Saxenda): Daily injection Dulaglutide (Trulicity): Weekly injection Semaglutide (Ozempic, Rybelsus, Wegovy): Weekly injection or daily pill Tirzepatide (Mounjaro, Zepbound): Weekly injection